Inventor · disambiguated record
Joshua Hummel
Also filed as: HUMMEL JOSHUA
9 granted patents·12 pending applications·59 citations·filing 2017–2025
86Inventor score
Files withINCYTE CORP21
Top patents by PatentIndex Score
21 records- 0197US11542265B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2021·Granted Jan 3, 2023·8 cites·43 claims
- 0295US10899755B2Benzothiazole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Jan 26, 2021·15 cites·39 claims
- 0394US11866426B2Benzothiazole compounds and uses thereofINCYTE CORP·Filed 2020·Granted Jan 9, 2024·3 cites·41 claims
- 0494US11472791B2Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitorsINCYTE CORP·Filed 2020·Granted Oct 18, 2022·7 cites·31 claims
- 0593US11981671B2Bicyclic pyrazolyl amines as CDK2 inhibitorsINCYTE CORP·Filed 2022·Granted May 14, 2024·2 cites·58 claims
- 0693US11976073B2Bicyclic amines as CDK2 inhibitorsINCYTE CORP·Filed 2022·Granted May 7, 2024·2 cites·65 claims
- 0792US11299473B2Benzimidazole and indole compounds and uses thereofINCYTE CORP·Filed 2019·Granted Apr 12, 2022·10 cites·56 claims
- 0892US11014929B2Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2019·Granted May 25, 2021·12 cites·54 claims
- 0979US12466828B2Bicyclic amines as CDK2 inhibitorsINCYTE CORP·Filed 2023·Granted Nov 11, 2025·0 cites·47 claims
- 1068US2025179083A1Tricyclic triazolo compounds as dgk inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1168US2025066363A1Bicyclic DGK InhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1267US2024415840A1Bicyclic amines as cdk2 inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 1365US2024270739A1Heteroaryl Fluoroalkenes As DGK InhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 1465US2024217989A1Heteroaryl Fluoroalkenes As DGK InhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 1565US2024083898A1Tricyclic triazolo compounds as dgk inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 1664US2025186450A1COMBINATION THERAPY COMPRISING DGK INHIBITORS and PD-1/PD-L1 INHIBITORSINCYTE CORP·Filed 2024·Application pending·0 cites
- 1762US2023192706A1Bicyclic amines as cdk2 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 1862US2023399342A1Tricyclic triazolo compounds as dgk inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 1959US2022340579A1Pyrazolyl bicyclic amines as cdk2 inhibitorsINCYTE CORP·Filed 2022·Application pending·0 cites
- 2053US2018072741A1Pyrazolopyrimidine compounds and uses thereofINCYTE CORP·Filed 2017·Application pending·0 cites
- 2147US2025263416A1SPPL2a INHIBITORSINCYTE CORP·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joshua Hummel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →